Ubs Global Asset Management Americas »

Cogent Biosciences shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $467k 70k 6.72
2023-12-31 $350k 60k 5.88
2023-09-30 $504k 52k 9.75
2023-06-30 $240k 22k 10.79
2023-03-31 $240k 22k 10.79
2022-12-31 $257k 22k 11.56

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Nvidia Corp Equity Us Cm (NVDA)
Amazon Equity Us Cm (AMZN)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Meta Platforms Equity Us Cm (META)
Ishares Core Msci Eafe Equity (IEFA)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Eli Lilly &#38 Equity Us Cm (LLY)
Broadcom Equity Us Cm (AVGO)
Tesla Equity Us Cm (TSLA)
Unitedhealth Group Equity Us Cm (UNH)
Advanced Micro Devices Equity Us Cm (AMD)
Visa Inc Class A Shares Equity Us Cm (V)
Jpmorgan Chase &#38 Company Equity Us Cm (JPM)

View all positions for Ubs Global Asset Management Americas

Top funds holding Cogent Biosciences

Kynam Capital Management
FMR
BlackRock
Point72 Asset Management
Commodore Capital
Vanguard Group
VR Adviser
Fairmount Funds Management
Redmile Group
Millennium Management
Sofinnova Ventures
Vivo Capital
Henderson Group
Morgan Stanley
Geode Capital Management

View all funds holding Cogent Biosciences